Cifty Tzb 1000 mg/125 mg Injection
By Cifty Tzb
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)

Manufacturer - Lancer Health Care Pvt Ltd
1572/15, 1st Floor, AC Market, Bhagirath Palace Near Central Bank Of India, Chandni Chowk, New Delhi - 110006, Delhi, India

Expires on or after
December, 2025

liver
When using Cifty Tzb 1000 mg/125 mg Injection, it's important to be cautious if you have severe liver disease. In such cases, the dosage of Cifty Tzb 1000 mg/125 mg Injection may need to be adjusted. It's crucial to consult your doctor before starting treatment with Cifty Tzb 1000 mg/125 mg Injection if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of Cifty Tzb 1000 mg/125 mg Injection is not typically recommended. Always follow your doctor's guidance and advice regarding the use of Cifty Tzb 1000 mg/125 mg Injection in relation to your liver health.

kidney
Limited data exists on the use of Cifty Tzb 1000 mg/125 mg Injection in people with kidney issues. It's recommended to seek advice from your doctor.

alcohol
When taking Cifty Tzb 1000 mg/125 mg Injection, it is safe to consume alcohol as it does not lead to any harmful effects.

driving
Cifty Tzb 1000 mg/125 mg Injection may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.

pregnancy
Cifty Tzb 1000 mg/125 mg Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Cifty Tzb 1000 mg/125 mg Injection should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹134.31
₹149.23
10% OFF
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024